Transcription factors drivers of malignancy and progression in breast cancer

  • 6,389

    Total Downloads

  • 18k

    Total Views and Downloads

About this Research Topic

Submission closed

Background

Breast cancer (BC) is the most diagnosed cancer in females worldwide and one of the leading causes of cancer deaths. BC is a heterogeneous disease composed of different BC subtypes with distinct molecular characteristics and genetic profiles: Normal-like, Luminal A, Luminal B, Human epidermal growth factor receptor 2 (HER2)-enriched and basal-like subtypes. Nearly overlapping with basal-like BCs, there are triple-negative BCs, which lack expression of estrogen receptor (ER), progesterone receptor (PR), and HER2. TNBCs are among the most aggressive BCs, presenting a higher 5-year mortality rate after treatment compared to other BCs.

Recent comprehensive analyses across cell types and cancer types have outlined a vast network of protein-protein associations between transcription factors. Not surprisingly, protein-protein networks central to oncogenesis and disease progression are highly altered during breast cancer pathogenesis. Overexpression and gain-of-function mutations in oncogenic transcription factors have shown to promote malignancy and progression of breast cancer through the activation of oncogenic programs, such as uncontrollable proliferation, epithelial-to-mesenchymal transition, stemness, drug and radiotherapy resistance, angiogenesis and metastasis. Examples of transcription factors playing a crucial role in those processes are ER, PR, p53, ENGRAILED 1, SOX2, MYC, BCL11A, HIFα, MCL1 and ZEB1. At the clinical level, the immunodetection of transcription factors on tumor specimens is part of routine testing and plays a role in making further clinical decisions. For instance, current biomarker determinations such as ER and PR expression guide treatment on BC patients. Nevertheless, more research in biomarker discovery is needed to accurately predict pathological complete response and patient outcomes, such as survival and progression risk.

From the therapeutic viewpoint, inhibiting the interactions between transcription factors represents a very significant challenge. Contact surfaces responsible for protein-protein interactions are relatively large and grooves or binding pockets minimal or absent. Consequently, the development of small-molecule inhibitors able to bind such featureless protein interfaces is extremely difficult. On the other hand, biologicals such as antibodies present a reduced membrane penetrability to bind and inhibit intracellular transcription factors. However, promising tools such as interference peptides, peptidomimetics, and engineered nanoparticles have emerged to offer a solution to the targeting problem. These therapeutics can further be linked to cell-penetrating peptides (CCP) to facilitate cellular internalization and enhance their therapeutic potential. CPP are usually short cationic or amphipathic peptides, able to interact with the negatively-charged biological membranes. One interesting natural compound acting as CPP is melittin which composes 50% of the dry weight of the honeybee venom and is able to induce apoptosis in cancer cells.

In this Research Topic, we aim to provide an overview of the recent advances in transcription factors relevant to breast cancer growth and progression and the development of different targeting approaches. We welcome Original Research articles, Reviews and Systematic Reviews covering but not limited to the following topics:

1. Discovery of novel transcription factors playing a role in breast cancer initiation and progression
2. Transcription factors as survival and prognosis-associated biomarkers for breast cancer in the clinic
3. Therapeutics targeting transcription factors in breast cancer: Cyclic peptides, peptide mimetics, small molecule inhibitors, antibodies and engineered nanoparticles, among others
4. Cell-penetrating peptides facilitating cellular internalization and/or inducing apoptosis in breast cancer
5. Clinical translation of transcription factor inhibitors for breast cancer

Keywords: Transcription factors, biomarkers, breast cancer, clinical trials, peptides, nanoparticles, melittin

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and they fall under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

      In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Impact

  • 18kTopic views
  • 11kArticle views
  • 6,389Article downloads
View impact